AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2025
May 28, 2025
31676_dirs_2025-05-27_241f699a-d65c-40d1-9172-52abbf9a5bd8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2025-05-22
Reporting Person: TANNENBAUM RENEE P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-22 | Common Stock | A | 4336 | — | Acquired | 26957 | Direct |
Footnotes
F1: Represents a restricted stock award that will vest in full on May 22, 2026.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3